First Implantations with MOVE-C Cervical Disc Prostheses from NGMedical

NGMedical GmbH located in Germany has announced the worldwide first implantations of its new MOVE-C disc prosthesis. After receiving CE approval end of December 2019, the first MOVE-C cervical disc prostheses were implanted in January.

The well thought through instrument set and the anatomical design of MOVE-C were crucial for the smooth surgeries. MOVE-C combines the features of a second generation disc prosthesis with the simple implantation technique of a cervical cage. The prosthesis offers physiological motion in all 6 planes including axial damping with progressive resistance to motion. Furthermore, MOVE-C is the first prosthesis with additively manufactured titanium endplates and avoids the use of PE.

NGMedical is specialized in motion preserving spinal implants as well as intelligent solutions for fusion surgery. With an experienced team of specialists and in cooperation with experienced spine surgeons NGMedical works on well thought through and tested solutions for state of the art spine surgery. In the near future, the new cervical BEE cage with a sophisticated honeycomb structure, which is purely manufactured additively, will be available.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.